These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1533574)

  • 21. Gestational and lactational exposition to Di-N-butyl-phthalate (DBP) increases inflammation and preneoplastic lesions in prostate of wistar rats after carcinogenic N-methyl-N-nitrosourea (MNU) plus testosterone protocol.
    Peixoto AR; Santos TM; Brandt JZ; Delella FK; Gonçalves BF; Campos SG; Taboga SR; Favaro WJ; Domeniconi RF; Scarano WR
    Environ Toxicol; 2016 Oct; 31(10):1185-95. PubMed ID: 25728413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a new topically active antiandrogen (RU 38882) on the rat sebaceous gland: comparison with cyproterone acetate.
    Bouton MM; Lecaque D; Secchi J; Tournemine C
    J Invest Dermatol; 1986 Feb; 86(2):163-7. PubMed ID: 2943819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea.
    Thompson HJ; Adlakha H; Singh M
    Carcinogenesis; 1992 Sep; 13(9):1535-9. PubMed ID: 1394836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinomas of the prostate induced by N-nitroso-N-methylurea in rats pretreated with cyproterone acetate and testosterone.
    Bosland MC; Prinsen MK; Kroes R
    Cancer Lett; 1983 Feb; 18(1):69-78. PubMed ID: 6218869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of orchiectomy, alone or in combination with testosterone, and cyproterone acetate on exocrine pancreatic carcinogenesis in rats and hamsters.
    Meijers M; Visser CJ; Klijn JG; Lamberts SW; van Garderen-Hoetmer A; de Jong FH; Foekens JA; Woutersen RA
    Int J Pancreatol; 1992 Apr; 11(2):137-46. PubMed ID: 1535094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptors in experimentally induced colon carcinogenesis.
    Izbicki JR; Wambach G; Hamilton SR; Harnisch E; Hogenschurz R; Izbicki W; Kusche J
    J Cancer Res Clin Oncol; 1986; 112(1):39-46. PubMed ID: 2942549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of mammary gland carcinomas by the subcutaneous injection of 1-methyl-1-nitrosourea.
    Thompson HJ; Meeker LD
    Cancer Res; 1983 Apr; 43(4):1628-9. PubMed ID: 6831409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
    McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE
    Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modifying effects of beraprost sodium (TRK-100) on N-methyl-N-nitrosourea (MNU) carcinogenesis in F344 rats].
    Kurata Y; Hagiwara A; Tamano S; Shibata M; Tanaka H; Yamada M; Ito H; Fukushima S
    J Toxicol Sci; 1989 Aug; 14 Suppl 1():1-39. PubMed ID: 2509723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary iodine deficiency as a tumor promoter and carcinogen in male F344/NCr rats.
    Ohshima M; Ward JM
    Cancer Res; 1986 Feb; 46(2):877-83. PubMed ID: 3940650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multistage transformation of cultured rat urothelium: the effects of N-methyl-N-nitrosourea, sodium saccharin, sodium cyclamate and 12-O-tetradecanoylphorbol-13-acetate.
    Knowles MA; Jani H
    Carcinogenesis; 1986 Dec; 7(12):2059-65. PubMed ID: 2430729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cyproterone acetate on growth and androgen metabolism of rat ventral prostate transplants.
    Thomas JA; Edwards WD; Felice PR
    Endocrinol Exp; 1981 Sep; 15(3):171-9. PubMed ID: 6457737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate carcinogenesis induced by N-methyl-N-nitrosourea (mnu) in gerbils: histopathological diagnosis and potential invasiveness mediated by extracellular matrix components.
    Gonçalves BF; Zanetoni C; Scarano WR; Góes RM; Vilamaior PS; Taboga SR; Campos SG
    Exp Mol Pathol; 2010 Feb; 88(1):96-106. PubMed ID: 19818764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of sex and carcinogen treatment protocol on tumor latency and frequency of K-ras mutations in N-methyl-N-nitrosourea-induced lymphomas.
    Romach E; Moore J; Rummel S; Richie E
    Carcinogenesis; 1994 Oct; 15(10):2275-80. PubMed ID: 7955066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of γ-tocopherol-enriched diet on N-methyl-N-nitrosourea-induced epithelial dysplasia in rat ventral prostate.
    Sanches LD; Santos SA; Carvalho JR; Jeronimo GD; Favaro WJ; Reis MD; Felisbino SL; Justulin LA
    Int J Exp Pathol; 2013 Dec; 94(6):362-72. PubMed ID: 24205794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymic lymphomas in Wistar rats exposed to N-methyl-N-nitrosourea (MNU).
    da Silva Franchi CA; Bacchi MM; Padovani CR; de Camargo JL
    Cancer Sci; 2003 Mar; 94(3):240-3. PubMed ID: 12824916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple pathways of prostate carcinogenesis analyzed by using cultured cells isolated from rats treated with N-methyl-N-nitrosourea and testosterone.
    Condon MS; Kaplan LA; Crivello JF; Horton L; Bosland MC
    Mol Carcinog; 1999 Jul; 25(3):179-86. PubMed ID: 10411144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin suppresses N-methyl-N-nitrosourea-induced photoreceptor apoptosis in Sprague-Dawley rats.
    Emoto Y; Yoshizawa K; Uehara N; Kinoshita Y; Yuri T; Shikata N; Tsubura A
    In Vivo; 2013; 27(5):583-90. PubMed ID: 23988891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenicity and organ specificity of N-trimethylsilylmethyl-N-nitrosourea (TMS-MNU), N-neopentyl-N-nitrosourea (neoPNU), and N-methyl-N-nitrosourea (MNU) in rats.
    Maekawa A; Onodera H; Kanno J; Furuta K; Nagaoka T; Todate A; Matsushima Y; Oh-hara T; Kawazoe Y
    J Cancer Res Clin Oncol; 1988; 114(5):473-6. PubMed ID: 3182906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone treatment is a potent tumor promoter for the rat prostate.
    Bosland MC
    Endocrinology; 2014 Dec; 155(12):4629-33. PubMed ID: 25247471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.